The effects of nutrition on plasma cholinesterase activity and cocaine toxicity in mice

Journal of Toxicology - Clinical Toxicology

Volumn 36, Issue 7, 1998, Pages 667-672

  Cahill Morasco, Raymond ^a   Hoffman, Robert S ^b,c   Goldfrank, Lewis R ^b  

^a TUFTS UNIVERSITY   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; COCAINE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ABUSE; ENZYME ACTIVITY; FEMALE; MOUSE; NONHUMAN; NUTRITIONAL STATUS; PROTEIN INTAKE; PROTEIN MALNUTRITION; SEIZURE;

ANIMALIA;

EID: 0031675544     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659809162614     Document Type: Article

References (29)

1. Stewart DJ, Inaba T, Lucassen M, Kalow W. Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther 1979; 25:464-468.
2. Jatlow P, Barash PG, Van Dyke C. Radding J, Byck R. Cocaine and succinylcholine sensitivity. A new caution. Anesth Analg 1979;58:235-238.
3. Devenyi P. Cocaine complications and pseudocholin-esterase. Ann Intern Med 1989;110:167-168.
4. Hoffman RS, Henry GL, Weisman RS, Howland MA, Goldfrank LR. Association between plasma cholinesterase activity and cocaine toxicity. Ann Emerg Med 1992;21:247-253.
5. Om A, Ellahham S, Ornato JP, et al. Medical complications of cocaine: Possible relationship to low plasma cholinesterase enzyme. Am Heart J 1993;125:1114-1117.
6. Hoffman RS, Henry GC, Wax PM, Weisman RS, Howland MA, Goldfrank LR. Decreased plasma cholinesterase activity enhances cocaine lethality in mice. J Pharmacol Exp Ther 1992;263:698-702.
7. Hoffman RS, Morasco R, Goldfrank LR. Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice. J Toxicol Clin Toxicol 1996;34:259-266.
8. Hoffman RS, Thompson T, Henry GC, Hatsukami DK, Pentel PR. Variation in human plasma cholinesterase activity during low dose cocaine administration. J Toxicol Clin Toxicol 1998;1&2:3-9.
9. Woods JW. Behavioral effects of cocaine in animals. In: Cocaine. Research Monograph #13, Peterson RC, Stillman RC, eds., National Institute on Drug Abuse, Rockville, MD, 1977:63-95.
10. Bieri JG, Stoewsand GS, Briggs GM, Phillips RW, Woodard JC, Knapka JJ. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J Nutrition 1977;107:1340-1348.
11. Bernhart FW, Tomarelli RM. A salt mixture supplying the National Research Counsel estimates of the mineral requirements of the rat. J Nutrition 1966;89: 495-499.
12. Kalow W, Lindsay HA. A comparison of optical and manometric methods for the assay of human serum cholinesterase. Can J Biochem Physiol 1955;33:568-574.
13. Inaba T, Stewart DJ, Kalow W. Metabolism of cocaine in man. Clin Pharm Ther 1978;23:547-552.
14. Stewart DJ, Inaba T, Tang BK, Kalow W. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci 1977;20:1557-1564.
15. Stewart DJ, Inaba T, Kalow W. N-demethylation of cocaine in the rat and in isolated rat hepatocytes: Comparison with aminopyrine demethylation. J Pharmacol Exp Ther 1978;207:171-177.
16. Leighty EG, Fentiman AF. Metabolism of cocaine to norcocaine and benzoylecgonine by an in vitro microsomal enzyme system. Res Comm Chem Pathol Pharmacol 1974;8:65-74.
17. Wilson MC, Bedford JA, Kibbe AH, Sam JA. Comparative pharmacology of norcocaine in M. Mulatta and M. Fascicularis. Pharmacol Biochem Behav 1978;9:141-145.
18. Borne RF, Bedford JA, Buelke JL, et al. Biological effects of cocaine, derivatives I: Improved synthesis and pharmacologic evaluation of norcocaine. J Pharm Sci 1977;66:119-129.
19. 3H]benzoylecgonine and pharmacological activity of some cocaine metabolites. J Pharm Pharmac 1975;27:784-786.
20. Just WW, Hoyer J. The local anesthetic potency of norcocaine, a metabolite of cocaine. Experientia 1977;30:70-71.
21. Dean RA, Christian CD, Sample RHB, Bosron WF. Human liver cocaine esterases: Ethanol-mediated formation of ethylcocaine. FASEB J 1991;5:2735-2739.
22. Spealman RD, Madras BK, Bergman J. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J Pharmacol Exp Ther 1989;231:142-149.
23. Madden JA, Powers RH. Effects of cocaine and cocaine metabolites on cerebral arteries in vitro. Life Sci 1990;47:1109-1114.
24. Ambre JJ, Fischman M, Ruo TI. Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans. J Anal Toxicol 1984;8:23-25.
25. Milhorat AT. The cholinesterase activity of the blood serum in disease. J Clin Invest 1938;17:649-657.
26. Faber M. The relationship between serum cholinesterase and serum albumen. Acta Med Scand 1943; 114:72-91.
27. Kaswin A. La cholinesterase du serum humain a l'etat physiologique et dans divers etats pathologiques. Presse Med 1945;53:713-714.
28. Hutchinson AD, McCance RA, Widdowson EM. Serum cholinesterases. Medical Research Council Special Report Series. H.M.S.O., London 1951, No. 275:216-225.
29. Cohen C. Serum pseudo-cholinesterase: A biochemical index of nutritional status in the elderly. Geront Clin 1964;6:321-330.